Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients

Clinical and Experimental Allergy

Volumn 33, Issue 5, 2003, Pages 595-599

  Asai, Kazuhisa ^a   Kanazawa, H ^a   Kamoi, H ^a   Shiraishi, S ^a   Hirata, K ^a   Yoshikawa, J ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Beclomethasone dipropionate; Bronchial asthma; Extravasation; Induced sputum; Vascular endothelial growth factor

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; VASCULOTROPIN;

ADULT; AIRWAY; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; SPUTUM ANALYSIS;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; CAPILLARY PERMEABILITY; ENDOTHELIAL GROWTH FACTORS; EOSINOPHILS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTE COUNT; LYMPHOKINES; MALE; MIDDLE AGED; SPUTUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037903433     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01576.x     Document Type: Article

References (23)

1. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156:229-33.
2. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148:1220-5.
3. Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subject. Thorax 2001; 56:902-6.
4. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146:1029-39.
5. Maniscalco WM, Watkins RH, D'Angio CT, Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 1997; 16:557-67.
6. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001; 107:295-301.
7. American Thoracic Society. Standards for the diagnosis and care of patients with chronic pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-44.
8. Yoshikawa T, Shoji S, Fujii T et al. Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur Respir J 1998; 12:879-84.
9. Van-Resen E-LJ, Hiemstra PS, Rabe KF, Sterk PJ. Assessment of microvascular leakage via sputum induction. Am J Respir Crit Care Med 2002; 165:1275-9.
10. Kanazawa H, Asai K, Hirata K, Yoshikawa J. Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest 2002; 122:166-70.
11. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995; 108:2369-79.
12. Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 1997; 57:765-72.
13. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998; 140:947-59.
14. Kanazawa H, Hirata K, Yoshikawa J. Role of endogenous nitric oxide in exercise-induced airway narrowing in patients with bronchial asthma. J Allergy Clin Immunol 2000; 106:1081-7.
15. Yong CL, Hern KL. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol 2001; 107:1106-7.
16. Demoly P, Maly FE, Mautino G et al. VEGF levels in asthmatic airways do not correlate with plasma extravasation. Clin Exp Allergy 1999; 29:1390-4.
17. Horiuchi T, Weller PF. Expression of vascular endothelial growth factor by human eosinophils: up-regulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 1997; 17:70-7.
18. Kanazawa H, Shoji S, Yoshikawa T, Hirata K, Yoshikawa J. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 1998; 28:1244-50.
19. Kanazawa H, Shoji S, Yamada M et al. Increased levels of nitric oxide derivatives in induced sputum in patients with asthma. J Allergy Clin Immunol 1997; 99:624-9.
20. Bandi N, Kompella UB. Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur J Pharmacol 2001; 425:109-16.
21. Brown KR, England KM, Goss KL, Snyder JM, Acarregui MJ. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 2001; 281:1001-10.
22. Boesiger J, Tsai M, Maurer M et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fc epsilon receptor I expression. J Exp Med 1998; 188:1135-45.
23. Fehrenbach H, Kasper M, Haase M, Schuh D, Muller M. Differential immunolocalisation of VEGF in rat and human adult lung, and in experimental rat lung fibrosis. Light, Fluorescence, Electronmicroscopy Anat Record 1999; 254:61-73.